Title | Pitocin-oxytocin - ATI active learning template |
---|---|
Author | abbie Bl |
Course | nursing care of women and families |
Institution | Madonna University US |
Pages | 1 |
File Size | 57.5 KB |
File Type | |
Total Downloads | 47 |
Total Views | 137 |
ATI active learning template...
ACTIVE LEARNING TEMPLATE:
Medication
lauren STUDENT NAME _____________________________________ pitocin/oxytocin MEDICATION __________________________________________________________________________
REVIEW MODULE CHAPTER ___________
CATEGORY CLASS ______________________________________________________________________
PURPOSE OF MEDICATION
Expected Pharmacological Action stimulates smooth muscle of uterus and mammary glands
Therapeutic Use induce labor, reduce postpartum bleeding, abortion
Complications subarachnoid hemorrhage, seizures, coma, arrhythmias, abruptio placentae, hemorrhage, anaphylaxis, death from oxytocin-induced water intoxication, uterine rupture, afibrinogenemia. HTN, PVCs, nausea, vomiting, tetanic uterine contractions, impaired uterine blood flow, pelvic hematoma, increased uterine motility. Fetal: brain damage, seizures, low Apgar scores at 5 minutes, death, bradycardia, arrhythmias, PVCs, retinal hemorrhage, jaundice
Medication Administration Never give drug simultaneously by more than one route, Don’t give bolus injection; use infusion pump. Give by piggyback infusion so that it may be stopped without interrupting IV line.
Contraindications/Precautions Contraindicated: when vaginal delivery isn’t advised, in fetal distress when delivery isn’t imminent, prematurity/other obstetric emergencies, patients with severe toxemia or hypertonic uterine patterns Caution: patients with invasive cervical cancer/previous cervical or uterine surgery (including cesarean section), grand multiparity, uterine sepsis, traumatic delivery, or overdistended uterus.
Interactions Carboprost tromethamine, Cyclopropane anesthetics, Dinoprostone, Drugs that prolong QT interval, Misoprostol, Vasoconstrictors
Nursing Interventions Patients on oxytocin must be under observation. Discontinue oxytocin infusion immediately if uterine hyperactivity or fetal distress occurs. Administer oxygen to mother. Use for induced labor only when pelvis is known to be adequate, vaginal delivery is indicated, fetal maturity is assured, and fetal position is favorable. Use drug only in hospital where critical care facilities and prescriber are immediately available. Monitor intake and output. Antidiuretic effect may lead to fluid overload, seizures, and coma from water intoxication. Monitor and record uterine contractions, HR, BP, intrauterine pressure, fetal HR, and character of blood loss at least every 15 minutes.
Client Education Evaluation of Medication Effectiveness client gives birth/client shows no sign of postpartum hemorrhage, fetus is aborted (if given for this reason)
ACTIVE LEARNING TEMPLATES
Explain use and administration of drug to patient and family. Instruct patient to promptly report adverse reactions (site irritation, nausea, bleeding, blurred vision, difficulty speaking, wheezing, itching, swelling).
THERAPEUTIC PROCEDURE
A7...